Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism.
- Published In:
- Experimental dermatology, 29(12), 1176-1185 (2020)
- Authors:
- Atazadeh, Fatemeh, Fazeli, Zahra, Vahidnezhad, Hassan, Namazi, Nastaran, Younespour, Shima, Youssefian, Leila, Abdollahimajd, Fahimeh, Uitto, Jouni
- Database ID:
- RPEP-04643
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04643APA
Atazadeh, Fatemeh; Fazeli, Zahra; Vahidnezhad, Hassan; Namazi, Nastaran; Younespour, Shima; Youssefian, Leila; Abdollahimajd, Fahimeh; Uitto, Jouni. (2020). Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism.. Experimental dermatology, 29(12), 1176-1185. https://doi.org/10.1111/exd.14200
MLA
Atazadeh, Fatemeh, et al. "Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism.." Experimental dermatology, 2020. https://doi.org/10.1111/exd.14200
RethinkPeptides
RethinkPeptides Research Database. "Increased level of cathelicidin (LL-37) in vitiligo: Possibl..." RPEP-04643. Retrieved from https://rethinkpeptides.com/research/atazadeh-2020-increased-level-of-cathelicidin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.